HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

SB 203580

a specific inhibitor of MAPKAP kinase-2 reactivating kinase; structure in first source
Also Known As:
4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole; SB-203580; SB203580; pyridine, 4-(5-(4-fluorophenyl)-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-4-yl)-
Networked: 513 relevant articles (20 outcomes, 38 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Wei, Duo: 9 articles (04/2006 - 05/2003)
2. Kipling, David: 6 articles (01/2013 - 11/2005)
3. Davis, Terence: 6 articles (01/2013 - 11/2005)
4. Marber, Michael S: 5 articles (06/2010 - 08/2003)
5. Kim, Jae-Ryong: 5 articles (01/2009 - 01/2003)
6. Lee, Kyung Hee: 5 articles (01/2009 - 01/2003)
7. Chen, Xu-lin: 5 articles (04/2006 - 04/2004)
8. Ben, Dao-feng: 5 articles (04/2006 - 04/2004)
9. Xia, Zhao-fan: 5 articles (04/2006 - 04/2004)
10. Kumphune, Sarawut: 4 articles (01/2015 - 05/2008)

Related Diseases

1. Inflammation
2. Anoxia (Hypoxia)
3. Burns
4. Necrosis
5. Colitis

Related Drugs and Biologics

1. p38 Mitogen-Activated Protein Kinases
2. Protein Kinases (Protein Kinase)
3. Phosphotransferases (Kinase)
4. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
5. salicylhydroxamic acid (SHAM)
6. Cytokines
7. Quercetin
8. Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
9. Methylprednisolone
10. Messenger RNA (mRNA)

Related Therapies and Procedures

1. Oral Administration
2. Topical Administration
3. Immunotherapy
4. Resuscitation
5. Therapeutics